Loading stock…

Kimberly-Clark Corporation (KMB) Stock Verdict & Ratings | Investment Bastion

02Growth

Is it actually growing, and how fast?

KMBKimberly-Clark

Revenue FY25$16.4B

GROWTH RATING↗

AVERAGE35 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR-7%1

Revenue, next 1Y+1%3

Revenue, next 3Y, CAGR+2%2

Revenue, next 5Y, CAGR+17%9

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+21%8

EPS growth, FY27E+1%4

EPS growth, FY28E+6%6

GROWTH ASSESSMENT

STRENGTHS

The runway holds up: revenue is set to grow 17%/yr over five years.9/10

Earnings are set to grow in step with sales (EPS about 6%/yr vs revenue 2%/yr).

WATCH

A mid-pack grower, ahead of 35% of companies worldwide.

Revenue is set to grow 2%/yr over the next 3 years, in line with the market.5/10

After shrinking over the last 3 years, revenue is set to grow 2%/yr from here.

WEAKNESSES

Revenue fell 7%/yr over the last 3 years, behind 90% of companies worldwide.1/10

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower that's turning around. The one thing to watch: revenue has shrunk over the past 3 years.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

WEAK19 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-6%4

3-month return-12%3

YTD return-1%5

MID & LONG-TERM▾SCORE

% of 52-week high82%6

1-year return-15%3

3-year return-8%2

5-year return-12%3

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

It's down 15% over the past year, now 18% below its 52-week high. That is right in line with the market.

Returns sit at the market level over the past month (-6%) and so far this year (-1%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-8.1% over three years and -12% over five), behind 70% of the market.

The stock is underperforming over three months (-12%).

BOTTOM LINE

Falling Knife

Returns rank poorly over both the short and long run, and the price is still falling. Momentum is firmly negative — catching this is a bet against the tape, not with it. Wait for a base to form. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Kimberly-Clark. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

KMBKimberly-Clark

Revenue FY25$16.4B

GROWTH RATING↗

AVERAGE35 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR-7%1

Revenue, next 1Y+1%3

Revenue, next 3Y, CAGR+2%2

Revenue, next 5Y, CAGR+17%9

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+21%8

EPS growth, FY27E+1%4

EPS growth, FY28E+6%6

GROWTH ASSESSMENT

STRENGTHS

The runway holds up: revenue is set to grow 17%/yr over five years.9/10

Earnings are set to grow in step with sales (EPS about 6%/yr vs revenue 2%/yr).

WATCH

A mid-pack grower, ahead of 35% of companies worldwide.

Revenue is set to grow 2%/yr over the next 3 years, in line with the market.5/10

After shrinking over the last 3 years, revenue is set to grow 2%/yr from here.

WEAKNESSES

Revenue fell 7%/yr over the last 3 years, behind 90% of companies worldwide.1/10

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower that's turning around. The one thing to watch: revenue has shrunk over the past 3 years.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

WEAK19 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-6%4

3-month return-12%3

YTD return-1%5

MID & LONG-TERM▾SCORE

% of 52-week high82%6

1-year return-15%3

3-year return-8%2

5-year return-12%3

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

It's down 15% over the past year, now 18% below its 52-week high. That is right in line with the market.

Returns sit at the market level over the past month (-6%) and so far this year (-1%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-8.1% over three years and -12% over five), behind 70% of the market.

The stock is underperforming over three months (-12%).

BOTTOM LINE

Falling Knife

04Value

Are you paying a fair price for it?

Stop guessing on Kimberly-Clark. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Kimberly-Clark Corporation

01Key Ratings

02Growth

03Price Momentum

04Value

Stop guessing on Kimberly-Clark. Get the full investment case.

Premium

02Growth

03Price Momentum

04Value

Stop guessing on Kimberly-Clark. Get the full investment case.

Premium